Patents by Inventor Andrew Swick

Andrew Swick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150093451
    Abstract: Methods are disclosed of the increasing resting metabolic rate of a subject comprising administering a composition comprising a mixture of reduced species and reactive oxygen species, wherein the mixture of reduced species and reactive oxygen species increases the resting metabolic rate of the subject. The reactive oxygen species can comprises at least one superoxide The process of making the composition comprises the steps of purifying water to produce ultra-pure water, combining sodium chloride to the ultra-pure water to create salinated water, and electrolyzing the salinated water at a temperature of about 4.5° C. to about 5.8° C. The electrolyzing is accomplished with an anode, a cathode and a power source. The power source comprises a transformer and a rectifier and does not comprise a filter capacitor. The method can also include contacting at least one cell of the subject with the composition.
    Type: Application
    Filed: September 9, 2014
    Publication date: April 2, 2015
    Inventors: David Neiman, Andrew Swick, Mark Snyder, Bristol Sorensen
  • Publication number: 20140056991
    Abstract: Methods of mobilizing fatty acids are disclosed.
    Type: Application
    Filed: September 9, 2013
    Publication date: February 27, 2014
    Inventors: David Nieman, Andrew Swick, Mark Snyder, Bristol Sorensen
  • Publication number: 20140050800
    Abstract: Methods of ameliorating cellular oxidative stress and reducing serum cholesterol are disclosed.
    Type: Application
    Filed: September 9, 2013
    Publication date: February 20, 2014
    Inventors: David Nieman, Andrew Swick, Mark Snyder, Bristol Sorensen
  • Publication number: 20070117805
    Abstract: The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to the diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides intermediates and processes for preparing these compounds.
    Type: Application
    Filed: October 13, 2006
    Publication date: May 24, 2007
    Inventors: Robert Dow, Kevin Liu, Bradley Morgan, Andrew Swick
  • Patent number: 7196257
    Abstract: The present invention discloses a method for determining an optimal piano hammer felt voicing technique for voicing an unvoiced tone in a piano so as to achieve a predetermined standard of tonal quality associated with a given voiced tone using a computer program. The method comprises a) creating a library comprising at least two records wherein each record comprises a transfer function and a voicing technique wherein said transfer function mathematically expresses the effect upon tonal quality of said voicing technique; b) determining the harmonic profile for each of said unvoiced and voiced tones; c) identifying the record in said library that contains the transfer function that is most similar to the voiced transfer function that would be calculated from the harmonic profiles of said unvoiced and voiced tones; and d) disclosing the voicing technique that is contained in said identified record.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: March 27, 2007
    Assignee: William Marsh Rice University
    Inventors: Andrew Swick, Douglas Duncan, Darius Roberts, Shannon Hughes
  • Publication number: 20060270655
    Abstract: Combination therapies for treating obesity or related eating disorders and/or reducing food consumption are described herein which comprises administering a therapeutically effective amount of a cannabinoid-1 (CB-1) receptor antagonist and an intestinal-acting microsomal triglyceride transfer protein inhibitor (MTPi) to an animal in need of such treatment. The CB-1 receptor antagonist and intestinal-acting MTPi may be administered separately or together.
    Type: Application
    Filed: May 16, 2006
    Publication date: November 30, 2006
    Inventors: Andrew Swick, Terrell Patterson
  • Publication number: 20040182227
    Abstract: The present invention discloses a method for determining an optimal piano hammer felt voicing technique for voicing an unvoiced tone in a piano so as to achieve a predetermined standard of tonal quality associated with a given voiced tone using a computer program. The method comprises a) creating a library comprising at least two records wherein each record comprises a transfer function and a voicing technique wherein said transfer function mathematically expresses the effect upon tonal quality of said voicing technique; b) determining the harmonic profile for each of said unvoiced and voiced tones; c) identifying the record in said library that contains the transfer function that is most similar to the voiced transfer function that would be calculated from the harmonic profiles of said unvoiced and voiced tones; and d) disclosing the voicing technique that is contained in said identified record.
    Type: Application
    Filed: December 15, 2003
    Publication date: September 23, 2004
    Applicant: WILLIAM MARSH RICE UNIVERSITY
    Inventors: Andrew Swick, Douglas Duncan, Darius Roberts, Shannon Hughes